Patients participating in clinical research through clinical trials perform better than others and being included in a trial is often the last hope for incurable patients. Strong clinical trial activity limits the travel of our patients for treatments in other regions, attracts outside patients in the Euregio and creates jobs thanks to the funds of the pharmaceutical industry. This action aims at optimizing patient access to clinical trials thanks to the creation of a cross-border platform offering a global service to all Euregio patients and doctors:
  1. A trans-regional database of clinical trials accessible to patients and doctors
  2. Practical information on each trial
  3. Integrated management of trials at the level of cancer centers
  4. Automatic data extraction to general scientific reports for institutions, ethics committees, national agencies